Investment for the biotech sector: Tigenix, Ekuore and Grants4Apps

Integral service around a transaction
BY : Diego GutiérrezSeptember Thu, 2015
One of the great challenges of the biotech sector in Spain is the growth of companies in the sector that will make it possible for Spanish biotech companies to be strong and compete in the international market. Getting funding in the sector is complicated but not impossible, in the last month we have witnessed how Spanish companies have grown through acquisitionspublic funding and programmes to support start-ups.


Tigenix buys CoreTheraphics

TiGenix a leading European cell therapy company with a strong platform of clinical-stage adult stem cell programmes and a marketed product, has acquired Spanish company Coretherapix, belonging to Genetrix and dedicated to the development of cardiac cell therapies.

The purchase allows Tigenix to enter new markets with a cardiac stem cell platform that could be developed for other heart diseases.

"In 2013 Grifols bought a 21.3% stake in Tigenix becoming its largest shareholder and is currently considering listing Tigenix on the US stock exchange," says Diego Gutierrez of Grifols. Abra-Invest.

Ekuore receives support from Europe

The company eKuoreone of the winning projects of Lanzadera, has received 50,000 euros of investment in the Horizon 2020 Programme. for the launch of its eKuore Pro medical stethoscope.

eKuore Pro, which will be launched in the last quarter of 2015, is the first stethoscope capable of transmitting auscultation to smartphones, tablets and audio equipment, and also measures beats per minute, records auscultation and filters the sound of the heart or lungs, with entirely Spanish technology.

The funding obtained is focused on feasibility studies, competitor studies, new business models, marketing, risk analysis and intellectual property studies.

Bayer brings Grants4Apps® initiative to Spain to support innovative healthcare startups

After three successful years in Berlin, the programme Grants4Apps  arrives in Spain through Grants4Apps Coworking Barcelona, an initiative aimed at startups with innovative e-health projects - from applications to medical devices, including software or hardware - that contribute to the improvement of health and/or pharmaceutical processes.

 The programme offers five startups a workspace in the offices of Bayer in Sant Joan Despí (Barcelona) for six months (from October to March) free of charge, with an office for each selected team and meeting rooms. The aim of this initiative is to support entrepreneurship and innovation in digital health by promoting and supporting projects aimed at health professionals and patients.

 In addition, the programme offers mentoring and coaching The Bayer Group's experts and external specialists will provide personalised advice and support, networkingThe G4A Chillout Networking area, contact with potential investors and a 'G4A Chillout Networking' area to enhance communication between the startups and Bayer employees.

Other posts that may interest you 

Biotechnology finds a new form of funding with Crowdfunding and Spain is one of the pioneers

Biotechnology grows and finds alternative forms of financing


The M&A Professionals

Meet our services



Do you want to be up to date?


Our diferentiation

Market Research Technology
Our team of market analysis specialists is continuously analyzing the investments of the most active markets in the industry in order to unceasingly contribute ideas of the current market situation and identify the most relevant trends for senior management. We integrate the most relevant sources of information which allows us to discover the most interesting companies for venture capital and similarly helps us to identify the investors with the highest probability of involvement in an M&A process to ensure the success of our sell-side operations.

The reports and deductions of our advisors provide a broad view of the sector, both geographically and from the complementary or adjacent markets perspective.
Technology Data Analytics
for M&A
Advanced data anlytics is a weapon". Intelfin is an artificial intelligence tool we use for investing and creating value in SMEs through competitive analytics and the enterprise environment.

IntelFin consists of a cognitive system, which, through the application of advanced analytical technologies, facilitates the automation of investment and financing decisions in the field of non-listed companies and especially SMEs in high-growth sectors.

The information related to these companies is characterized by their lack of transparency and heterogeneity; thus, it is necessary to develop an advanced analysis which is as much predictive as prescriptive and is developed in a natural language custom, suitable to obtain greater clarity and knowledge of the investment scope.

The IntelFin system focuses especially on analyzing the variables that define and influence the competitive environment of a sector and the positioning of a company, analyzing their influence on future value creation. Therefore, IntelFin supports strategic decision-making to senior management by resolving questions such as:

¿What are my competitors' priorities, strategies and expansion plans? Who's my competition? Which competitor is most likely to grow at a higher rate?
Which areas of activity/business models will receive the most investment? Which sectors are most attractive to investors?
Which companies are going to experience the most growth in the near future? Which companies are most likely to receive investment or be acquired?
Training Methodology
We have developed training programs in an innovative set-up which guarantees our teams the acquisition of technical competences both in the field of corporate finance and in the field of psychology, that is much needed when it comes to negotiation processes.

We have a culture of continuous improvement of our processes, closely related to the use of information systems that allow the enhancement of internal communication between our teams, as well as external communication with our customers. Hence, we extend best practices identified internally in an efficient and rapid manner among our members.

Are you one of those who prefer to be well informed when making decisions?